Marianne Quiding-Järbrink

6PUBLICATIONS
33CO-AUTHORS
Metabolic medicineHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 24, 2026
Dynamic Responses to an Inflammatory Challenge Distinguish Metabolic Health Across Lean and Obese Individuals.

|Jul 02, 2024
γδ T cells in human colon adenocarcinomas comprise mainly Vδ1, Vδ2, and Vδ3 cells with distinct phenotype and function.

William Rodin, Louis Szeponik, Tsvetanka Rangelova

|Feb 12, 2024
Immune checkpoint blockade improves the activation and function of circulating mucosal-associated invariant T (MAIT) cells in patients with non-small cell lung cancer.

Patrik Sundström, Nikita Dutta, William Rodin

|Mar 11, 2023
Immune Microenvironment in Sporadic Early-Onset versus Average-Onset Colorectal Cancer.

Fanny Andric, Ala Al-Fairouzi, Yvonne Wettergren

|Oct 23, 2021
Antigen Presenting Cells from Tumor and Colon of Colorectal Cancer Patients Are Distinct in Activation and Functional Status, but Comparably Responsive to Activated T Cells.

Frank Liang, Azar Rezapour, Louis Szeponik

|Apr 22, 2021
Exhaustion in tumor-infiltrating Mucosal-Associated Invariant T (MAIT) cells from colon cancer patients.

William Rodin, Patrik Sundström, Filip Ahlmanner

Pageof 1

Frequent Collaborators

2 joint publications

Elinor Bexe-Lindskog

1 joint publications

Nikita Dutta

1 joint publications

William Rodin

1 joint publications

Andreas Hallqvist